Search for: "Austin v. Davis" Results 1 - 20 of 210
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Follow @ljstprof Austin Sarat is the William Nelson Cromwell Professor of Jurisprudence and Political Science at Amherst College. [read post]
20 Dec 2024, 6:30 am
Macey (Yale Law School), on Tuesday, December 17, 2024 Tags: Delaware Court of Chancery, moelis, Shareholders, Tornetta v. [read post]
20 Dec 2024, 6:30 am
Macey (Yale Law School), on Tuesday, December 17, 2024 Tags: Delaware Court of Chancery, moelis, Shareholders, Tornetta v. [read post]
20 Sep 2024, 6:30 am
Liekefett and Derek Zaba, Sidley Austin LLP, on Friday, September 13, 2024 Tags: Elections, Proxy season, SEC, Shareholders Debt portability provides a lifeline for M&A Posted by Binoy Dharia and Justin Wagstaff, White & Case LLP, on Saturday, September 14, 2024 Tags: Debt, M&A, Market, Short-term Are Fintechs Prepared for More Regulatory Scrutiny? [read post]
20 Sep 2024, 6:30 am
Liekefett and Derek Zaba, Sidley Austin LLP, on Friday, September 13, 2024 Tags: Elections, Proxy season, SEC, Shareholders Debt portability provides a lifeline for M&A Posted by Binoy Dharia and Justin Wagstaff, White & Case LLP, on Saturday, September 14, 2024 Tags: Debt, M&A, Market, Short-term Are Fintechs Prepared for More Regulatory Scrutiny? [read post]
11 Aug 2024, 12:25 pm by Josh Blackman
New Mexico (Confrontation Clause) Joined amicus brief of blue and red states in Davis v. [read post]
26 Jul 2024, 6:30 am
Cohen, Tami Stark and Ladan Stewart, White & Case LLP, on Saturday, July 20, 2024 Tags: ALJs, SEC, SEC v. [read post]
26 Jul 2024, 6:30 am
Cohen, Tami Stark and Ladan Stewart, White & Case LLP, on Saturday, July 20, 2024 Tags: ALJs, SEC, SEC v. [read post]
19 Jul 2024, 6:30 am
Kurt von Moltke, Jenner & Block LLP, on Saturday, July 13, 2024 Tags: Cybersecurity, Disclosure, Form 8-K, SEC The director’s guide to shareholder activism Posted by Matt DiGuiseppe, PricewaterhouseCoopers LLP, on Sunday, July 14, 2024 Tags: Activism, Activists, Board of Directors, Shareholders, Universal Proxy DEI: How to lead without going offside Posted by Simon Kerr-Davis and Laurie Ollivent, Linklaters LLP, on Monday, July 15, 2024 Tags: Board of Directors, D&I,… [read post]
19 Jul 2024, 6:30 am
Kurt von Moltke, Jenner & Block LLP, on Saturday, July 13, 2024 Tags: Cybersecurity, Disclosure, Form 8-K, SEC The director’s guide to shareholder activism Posted by Matt DiGuiseppe, PricewaterhouseCoopers LLP, on Sunday, July 14, 2024 Tags: Activism, Activists, Board of Directors, Shareholders, Universal Proxy DEI: How to lead without going offside Posted by Simon Kerr-Davis and Laurie Ollivent, Linklaters LLP, on Monday, July 15, 2024 Tags: Board of Directors, D&I,… [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
24 Dec 2023, 9:05 pm by The Regulatory Review
Barajas, University of California, Davis Regulators must redress transportation inequities in rural and disadvantaged communities. [read post]
6 Nov 2023, 2:42 pm by bndmorris
Patrick Metze was quoted in the following article: Serena Lin, Austin Am. [read post]